In our group of pathogenic NTHL1 biallelic variant carriers, it is evident that, as described in the literature, polyposis, CRC and BC are the main phenotype characteristics of this syndrome (Kuiper et al., 2020; Grolleman et al., 2019). The gene discussed is NTHL1; the disease is breast cancer.